HDAC2 and chronic obstructive pulmonary disease: Targeting these functional changes associated with steroid resistance and inflammation, by decreasing Pgp expression and upregulating GCR, HDAC2 and Hsp90 in NKT-like and NK cells, may improve patient morbidity and reduce the comorbid conditions associated with COPD.